Top

Journal of Cancer Survivorship

Published in:

01-03-2010

Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California Health Interview Survey

Authors: Erica S. Breslau, Diana D. Jeffery, William W. Davis, Richard P. Moser, Timothy S. McNeel, Sarah Hawley

Published in: Journal of Cancer Survivorship | Issue 1/2010

Abstract

Introduction

Women treated for breast cancer are at increased risk for developing second or new cancers. This study examined behavioral and health care utilization practices associated with screening behaviors for mammography, Papanicolaou (Pap), home fecal occult blood test (FOBT) and endoscopy (flexible sigmoidoscopy, colonoscopy, proctoscopy) among racially and ethnically diverse female breast cancer survivors (BCS) and women without a cancer history.

Methods

Data from the 2001 and 2003 California Health Interview Survey (CHIS), a random-digit dial population-based survey of adult respondents was used to examine self-reported screening practices of BCS (n = 1,502) and women without a cancer history (n = 31,911).

Results

Compared to women without a cancer history, BCS reported more recent screening for all tests. Among BCS, Hispanics reported lowest screening for routine mammography (84.2% versus 68.9%; P < 0.05) but highest screening for Pap test (95.4% versus 85.4%; P > 0.01). White and Asian BCS reported more endoscopic examinations (58.9% versus 46.5%; P < 0.001; 61.2% versus 38.4%; P < 0.05) than the comparison population. After adjustment for demographic, socioeconomic, and health status differences, screening rates for BCS showed higher mammography use (odds ratio [OR] 1.97; 95% confidence interval [95% CI] 1.58–2.46), Pap test (OR 1.44; 95% CI 1.22–1.70), and endoscopic use (OR 1.35; 95% CI 1.16–1.58), but not higher for FOBT.

Conclusions

Even though BCS generally had higher cancer screening rates than women without a cancer history, racial/ethnic differences exist among the type of test received. Narrowing these differences is essential to lessen disparities.

Implications for cancer survivors

The need for screening guidelines for BCS remains a high priority. Survivors would benefit from the frequency of screening for all cancers post-treatment.

Howe HL, Wu X, Ries LA, Cokkinides V, Ahmed F, Jemal A, et al. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer. 2006;107:1711–42.CrossRefPubMed

Ries LAG, Melbert D, Karpcho M, Stinchcomb D, Howlander N, Horner MJ, et al (eds). SEER cancer statistics review, 1975–2005, National Cancer Institute. Bethesda, MD. Based on November 2007 SEER data submission, posted to the SEER Web site, 2008. Web site: http://seer.cancer.gov/csr/1975_2005. Accessed July 21, 2009.

Earle CC, Burstein HJ, Winer EP, Weeks J. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol. 2003;21:1447–51.CrossRefPubMed

Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LAG, et al. Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. JNCI Cancer Spectrum. 2005;97(19):1407–27.

Ries L, Eisner M, Kosary C, et al. SEER cancer statistics review, 1975–2001. Bethesda: National Cancer Institute; 2005. Web Site: http://seer.cancer.gov/csr/1975_2001/. Accessed July 21, 2009.

Smith TJ, Davidson NE, Schapira DV, et al. American Society of Clinical Oncology 1998. Update of recommended breast cancer surveillance guidelines. J Clin Oncol. 1999;17:1080–2.PubMed

National Comprehensive Cancer Network. Clinical practice guidelines in oncology. V.2.2008 Breast cancer screening and diagnosis guidelines. 2008. Web Site: http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf. Accessed July 21, 2009.

Andersen RM, Urban N. The use of mammography by survivors of breast cancer. Am J Pub Health. 1998;88:1713–5.CrossRef

Phillips KA, Morrison KR, Andersen R, Aday LA. Understanding the context of health care utilization: assessing environmental and provider-related variables in the behavioral model of utilization. HSR. 1998;33:571–96.PubMed

10.

Aday LA, Andersen R. A framework for the study of access to medical care. HSR. 1974;9:208–20.PubMed

11.

Phillips KA, Kerlikowske K, Baker LC, Chang SW, Brown ML. Factors associated with women’s adherence to mammography screening guidelines. HSR. 1998;33:29–53.PubMed

12.

Phillips KA, Haas JS, Su-Ying L, Baker LC, Tye S, Kerlikowske K, et al. Are gatekeeper requirements associated with cancer screening utilization? HSR. 2004;39:153–78.PubMed

13.

Liang SY, Phillips KA, Nagamine M, Ladabaum U, Haas JS. Rates and predictors of colorectal cancer screening. Prevent Chronic Disease. 2006;3:1–13.CrossRef

14.

Lash TL, Silliman RA. Medical surveillance after breast cancer diagnosis. Med Care. 2001;39:945–55.CrossRefPubMed

15.

Mandleblatt JS, Lawrence WF, Cullen J, Stanton AL, Krupnick JL, Kwan L, et al. Patterns of care in early-stage breast cancer survivors in the first year after cessation of active treatment. J Clin Oncol. 2006;24:77–84.CrossRef

16.

Silliman RA, Ganz PA. Adjuvant chemotherapy use and outcomes in older women with breast cancer: what have we learned? J Clin Oncol. 2006;20(24):2697–9.CrossRef

17.

Mayer DK, Terrin NC, Menon U, Kreps GL, McCance K, Parsons SK, et al. Screening practices in cancer survivors. J Cancer Surviv. 2007;1:17–26.CrossRefPubMed

18.

Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol. 2006;24:85–94.CrossRefPubMed

19.

Trask PC, Rabin C, Rogers ML, Whiteley J, Nash J, Frierson G, et al. Cancer screening practices among cancer survivors. Am J Prev Med. 2005;4:351–6.CrossRef

20.

Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Beh. 1995;36:1–10.CrossRef

21.

Taylor R, Davis P, Boyages J. Long-term survival of women with breast cancer in New South Wales. Eur J Cancer. 2003;39:215–22.CrossRefPubMed

22.

Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomized trials. Lancet. 2002;359:909–19.CrossRefPubMed

23.

Hatteville L, Mahe C, Hill C. Prediction of the long-term survival in breast cancer patients according to the present oncological status. Stat Med. 2002;21:2345–54.CrossRefPubMed

24.

Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, et al. 14 years of follow-up from the Edinburgh randomized trial of breast-cancer screening. Lancet. 1999;353:1903–8.CrossRefPubMed

25.

Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol. 2005;23:276–92.CrossRefPubMed

26.

Soerjomataram I, Louwman WJ, Duijm LEM, Coebergh JWW. Rising incidence of breast cancer among female cancer survivors: implications for surveillance. Br J Cancer, Web Site: http://www.nature.com/bjc/journal/vaop/ncurrent/full/6604816a.html. Accessed July 21, 2009.

27.

Lash TL, Fox MP, Buist DS, Wei F, Field TS, Frost FJ, et al. Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol. 2007;20(25):3001–6.CrossRef

28.

Bellizzi KM, Rowland JH, Jeffery DD, McNeel T. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol. 2005;23:8884–93.CrossRefPubMed

29.

Field TS, Doubeni C, Fox MP. Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med. 2008;23:158–63.CrossRefPubMed

30.

Doubeni CA, Field TS, Yood MU, Rolnick SJ, Quessenberry CP, Fouayzi H, et al. Patterns and predictors of mammography utilization among breast cancer survivors. Cancer. 2006;106:2482–8.CrossRefPubMed

31.

Sepucha KR, Belkora JK, Mutchnick S, Esserman LJ. Consultation planning to help breast cancer patients prepare for medical consultations: effect on communication and satisfaction for patients and physicians. J Clin Oncol. 2002;20:2695–700.CrossRefPubMed

32.

Sepucha KR, Fowler FJ, Mulley AJ. Policy support for patient-centered care: the need for measurable improvements in decision quality. Health Affairs, 2004: Supp. Web Exclusive VAR: 54–62. Web site: http://www.healthaffairs.org. Accessed July 21, 2009.

33.

National Comprehensive Cancer Network: NCCN practice guidelines in oncology, V1.2005. Web site: http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf. Accessed July 21, 2009.

34.

Ponce NA, Lavarreda SA, Yen W, Brown ER, DiSogra C, Satter DE. The California Health Interview Survey 2001: translation of a major survey for California’s multiethnic population. Public Health Rep. 2004;119:388–93.CrossRefPubMed

35.

Sheinfeld Gorin S, Gauthier J, Hay J, Miles A, Wardel J. Cancer screening and aging: research barriers and opportunities. Cancer. 2008;113(12 Suppl):3493–504.PubMed

36.

Berman JM, Cheung RJ, Weinberg DS. Surveillance after colorectal cancer resection. Lancet. 2000;355:395–9.CrossRefPubMed

37.

Burnstein HJ, Winer EP. Primary care for survivors of breast cancer. NEJM. 2000;343:1086–94.CrossRef

38.

Schapira MM, McAuliffe TL, Nattinger AB. Underutilization of mammography in older breast cancer survivors. Med Care. 2000;38:281–9.CrossRefPubMed

39.

Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Surveillance testing among survivors of early-stage breast cancer. J Clin Oncol. 2007;25:1074–81.CrossRefPubMed

40.

Smith TJ, Davidson NE, Schapira DV, et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol. 1999;17:1080–2.PubMed

41.

Institute of Medicine Report. Ensuring quality cancer care. In: Hewitt M, Simone JV, editors. National cancer policy board, institute of medicine report and national research council. Washington: National Academy; 1999.

42.

California Health Interview Survey. CHIS 2001 methodology series, report 1: sample design. 2002. Web site: http://www.chis.ucla.edu/methods.html. Accessed July 21, 2009.

43.

California Health Interview Survey. CHIS 2003 methodology series, report 1: sample design. 2005. Web site: http://www.chis.ucla.edu/methods.html). Accessed July 21, 2009.

44.

California Health Interview Survey. CHIS methodology series: inference using cross sectional surveys for multiple years. 2006. Web site: http://www.chis.ucla.edu/methods.html. Accessed July 21, 2009.

45.

Screening for Cervical Cancer. January 2003. U.S. Preventive Services Task Force. Agency for Health Care Research and Quality, Rockville, MD. Web site: http://www.ahrq.gov/clinic/uspstf/uspscerv.htm. Accessed July 21, 2009.

46.

Screening for Colorectal Cancer. July 2002. U.S. Preventive Services Task Force. Agency for Health Care Research and Quality, Rockville, MD. Web site: http://www.ahrq.gov/clinic/uspstf/uspscol.htm. Accessed July 21, 2009.

47.

Research Triangle Institute. SUDAAN example manual: release 9.0. 2004. Research Triangle Park, NC: Research Triangle Institute.

48.

U.S. Census Bureau, U.S. Department of Commerce, U.S. Hispanic Population Surpasses 45 Million Now 15 Percent of Total. Press Release, May 1, 2008. Web access: http://www.census.gov/Press-Release/www/releases/archives/population/011910.html. Accessed July 21, 2009.

49.

Ayanian JZ, Kohler BA, Abe T, Epstein AM. The relation between health insurance coverage and clinical outcomes among women with breast cancer. NEJM. 1993;329:326–31.CrossRefPubMed

50.

De Alba I, Hubbell FA, McMullen JM, Sweningson JM, Saitz R. Impact of U.S. citizenship status on cancer screening among immigrant women. J Gen Intern Med. 2005;20:290–6.CrossRefPubMed

51.

Kagawa-Singer M, Pourat N, Breen N, Coughlin S, Abend McLean T, McNeel TS, et al. Breast and cervical cancer screening rates of subgroups of Asian American women in California. Med Care Res Rev. 2007;64:706–30.CrossRefPubMed

52.

Crawley LM, Ahn DK, Winkleby MA. Perceived medical discrimination and cancer screening behaviors of racial and ethnic minority adults. Cancer Epidemiol Biomark Prev. 2008;17:1937–44.CrossRef

53.

Haas JS, Phillips KA, Sonneborn D, McCulloch CE, Liang SY. Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States. Med Care. 2002;40:743–51.CrossRefPubMed

54.

Ashing-Giwa KT, Padilla G, Tejero J, et al. Understanding the breast cancer experience of women: a qualitative study of African American, Latina and Caucasian cancer survivors. Psychooncology. 2004;13(6):408–28.CrossRefPubMed

55.

Tu SP, Taplin SH, Barlow WE, Boyko EJ. Breast cancer screening by Asian-American women in a managed care environment. Am J Prev Med. 1999;17:55–61.CrossRefPubMed

56.

Hewitt M, Breen N, Devesa S. Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey. J Natl Cancer Inst. 1999;91:1480–6.CrossRefPubMed

57.

Yabroff KR, Lawrence F, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96:1322–30.PubMedCrossRef

58.

Sillman RA, Troyan SL, Guadagnoli E. The impact of age, marital status, and physician-patient interactions on the care of older women with breast carcinoma. Cancer. 1997;80:1326–34.CrossRef

59.

Wallace LS, DeVoe JE, Rogers ES, Malagon-Rogers M, Fryer GE. The medical dialogue: disentangling differences between Hispanics and non-Hispanic Whites. J Gen Intern Med. 2007;22:1538–43.CrossRefPubMed

60.

Vogel VG. Identifying and screening patients at risk of second cancers. Cancer Epidemiol Biomark Prev. 2006;15(11):2027–32.CrossRef

61.

Travis LB. The epidemiology of second primary cancers. Cancer Epidemiol Biomark Prev. 2006;15:2020–6.CrossRef

62.

Liang SY, Phillips K, Hass J, Sakowski J. Health plan choice and use of cancer screening. Acad Health Serv Res Health Policy Meet. 2002;19:25–9.

63.

Corbie-Smith G, Flagg EW, Doyle JP, O’Brien MA. Influence of usual source of care on differences by race/ethnicity in receipt of preventive services. J Gen Intern Med. 2002;17:458–64.CrossRefPubMed

64.

Desai MM, Bruce ML, Desai RA, Druss BG. Validity of self-reported cancer history: a comparison of health interview data and cancer registry records. Am J Epidemiol. 2001;153:299–306.CrossRefPubMed

Title: Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California Health Interview Survey
Authors: Erica S. Breslau
Diana D. Jeffery
William W. Davis
Richard P. Moser
Timothy S. McNeel
Sarah Hawley
Publication date: 01-03-2010
Publisher: Springer US
Published in: Journal of Cancer Survivorship / Issue 1/2010
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-009-0102-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusions

Implications for cancer survivors

Please log in to get access to this content

Other articles of this Issue 1/2010

Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors

Development of a health-related website for parents of children receiving hematopoietic stem cell transplant: HSCT-CHESS

Surveillance mammography for Medicaid/Medicare breast cancer patients

Cancer-related communication, relationship intimacy, and psychological distress among couples coping with localized prostate cancer

The role of occupational upper extremity use in breast cancer related upper extremity lymphedema

Health-related behavior change after cancer: results of the American Cancer Society’s studies of cancer survivors (SCS)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer